Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

British American Tobacco: Buy, Sell, or Hold?
British American Tobacco: Buy, Sell, or Hold?

There's no way to sugarcoat the trade-off being made by British American Tobacco (NYSE: BTI) shareholders. You're getting a massive 9.7% dividend yield, but you are taking on a huge amount of risk

This Dividend King's Yield Has Never Been This High. Time to Buy the Stock?
This Dividend King's Yield Has Never Been This High. Time to Buy the Stock?

Dividend stocks with high yields are often a red flag. When investors don't trust the dividend, the share price falls, and the yield rises abnormally high. A company that consistently raises its

Where Will Moderna Stock Be in 5 Years?
Where Will Moderna Stock Be in 5 Years?

Moderna (NASDAQ: MRNA) was a top stock to own during the early stages of the pandemic. The COVID-19 vaccine maker reached a market cap of nearly $200 billion at its peak in 2021. But nowadays, with

Billionaire Dan Loeb Has 27% of His Third Point Portfolio in 3 Brilliant "Magnificent Seven" Stocks, but Completely Sold Out of Another
Billionaire Dan Loeb Has 27% of His Third Point Portfolio in 3 Brilliant "Magnificent Seven" Stocks, but Completely Sold Out of Another

Daniel Loeb is something of an iconic figure in the annals of Wall Street. The billionaire is CEO of Third Point, the hedge fund he founded in 1995. Loeb secured his place in investor history by

Better Blockbuster-Drug Stock: Novo Nordisk vs. Eli LillyPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Better Blockbuster-Drug Stock: Novo Nordisk vs. Eli Lilly

Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are two of the hottest pharmaceutical stocks of the past three years. Both companies have marked returns far in excess of the market's, thanks to

Is Ginkgo Bioworks Destined to Be in a "Magnificent Seven" of Healthcare Stocks?Photo, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Is Ginkgo Bioworks Destined to Be in a "Magnificent Seven" of Healthcare Stocks?

Could Ginkgo Bioworks Holdings (NYSE: DNA) one day be part of the healthcare sector's version of the "Magnificent Seven" group of high-performing stocks? It's more likely than you think. The

Will Coca-Cola Stock Finally Beat the Market This Year?Photo, wide shot, wide-angle lens,  Specialty food store, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/7a8f69d5-c26e-46d9-b403-d3e5e9562eca.png
Will Coca-Cola Stock Finally Beat the Market This Year?

Coca-Cola (NYSE: KO) is one of the most recognized brands on Earth with a top-10 global brand value. It's a Warren Buffett favorite, and it's the top-selling beverage company in the world.

So it

3 Magnificent Dividend Stocks to Buy Hand Over Fist in MarchPhoto, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
3 Magnificent Dividend Stocks to Buy Hand Over Fist in March

Dividend stocks can be magnificent investments. Not only do they provide passive income, but they can also produce above-average total returns as they grow their earnings and shareholder payouts.

Alphabet Falls From 3rd- to 5th-Largest U.S. Company. Should You Buy, Sell, or Hold the Stock?
Alphabet Falls From 3rd- to 5th-Largest U.S. Company. Should You Buy, Sell, or Hold the Stock?

Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) is better known by some of the brands it owns, like Google and YouTube. It's one of the largest tech companies and one of the members of the exclusive

Here's Why Block Stock Is a No-Brainer Buy TodayPhoto, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
Here's Why Block Stock Is a No-Brainer Buy Today

Block (NYSE: SQ) stock surged higher last week after the company announced its fourth-quarter results and provided guidance for 2024. Investors were pleased to see the company's cost-cutting efforts

Here's How Much You'd Have If You Invested $10,000 in Apple Stock When Warren Buffett First Bought ItPhoto, wide shot, wide-angle lens,  Telecom equipment supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/ad10ed87-71d0-4096-a50b-ba9470f8264b.png
Here's How Much You'd Have If You Invested $10,000 in Apple Stock When Warren Buffett First Bought It

Warren Buffett told Berkshire Hathaway shareholders last year that Apple (NASDAQ: AAPL) was a "better business than any we own." And he has put his money where his mouth is through the years.

Apple

2 Retail Giants Making Investors Richer With Dividend RaisesPhoto, wide shot, wide-angle lens,  Specialty food store, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/7a8f69d5-c26e-46d9-b403-d3e5e9562eca.png
2 Retail Giants Making Investors Richer With Dividend Raises

Our first earnings season of calendar 2024 is all but over, and like any earnings season, it's left some dividend raises in its wake. Companies like to declare dividends concurrently or near the

Can Cava Become the Next Chipotle?Photo, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
Can Cava Become the Next Chipotle?

Cava (NYSE: CAVA) just reported revenue of $175.5 million (up 52.5% year over year) and diluted earnings per share of $0.02 (compared to a $13.72 year-ago loss) for the 13-week period that ended

This Is My Favorite Account For Building a Millionaire Retirement
This Is My Favorite Account For Building a Millionaire Retirement

When it comes to trying to build a retirement nest egg to at least a $1 million balance, one account type stands out above all others: the Roth 401(k). Indeed, that type of plan has so much going

4 Must-Know Facts About Shopify Before You Buy the StockPhoto, wide shot, wide-angle lens, soft focus,  IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D
4 Must-Know Facts About Shopify Before You Buy the Stock

Shopify's (NYSE: SHOP) fourth-quarter financials came in better than expected. But soft guidance sent shares of the e-commerce platform lower as they're down almost 17% from their 2024 peak.

Adding $1,000 to These Top Growth Stocks Would Be a Brilliant MovePhoto, wide shot, wide-angle lens,  Janitorial service, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/4d4e885c-79e9-4b8f-bd91-e9721cd7c2e9.png
Adding $1,000 to These Top Growth Stocks Would Be a Brilliant Move

Looking for great stocks to buy in a bull market has its downsides. For instance, it's harder to find deep discounts during a bull run. However, that's not a big problem provided investors put their

Willing to Take on More Risk? These Big-Time Dividend Stocks Could Turn $7,500 Into More Than $1,000 of Annual Income.
Willing to Take on More Risk? These Big-Time Dividend Stocks Could Turn $7,500 Into More Than $1,000 of Annual Income.

High-yield dividend stocks are typically riskier than their lower-yielding peers. The underlying companies usually have high dividend payout ratios, which doesn't leave much room for error. If

Ride-Hailing Is Uber's Big Moneymaker, But That Could Change in the Future. Should Investors Care?
Ride-Hailing Is Uber's Big Moneymaker, But That Could Change in the Future. Should Investors Care?

If you asked 10 different people what Uber Technologies (NYSE: UBER) does, all 10 would likely say Uber is in the "ride-hailing" business. They'd be right. For investors, though, there's an

SoundHound AI Stock Took a Hit. Is It Time to Buy the Artificial Intelligence Stock?Photo, wide shot, wide-angle lens,  Networking equipment supplier, sunset photo at golden hour, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/66e3509e-f4c6-4a7b-8e88-53fcc02cf17f.png
SoundHound AI Stock Took a Hit. Is It Time to Buy the Artificial Intelligence Stock?

On the heels of an explosive rally, SoundHound AI (NASDAQ: SOUN) stock is seeing a big pullback. The audio-tech company reported its fourth-quarter earnings results after the market closed Thursday

Here's Why You Really Don't Want to Retire in Your 30s or 40s
Here's Why You Really Don't Want to Retire in Your 30s or 40s

Retiring in your 30s or 40s probably sounds impossible, and for a lot of people, it is. But for followers of the Financial Independence, Retire Early (FIRE) movement, it's the ultimate goal. These

Dollar General Stock Has Rebounded 40% From Its Recent Lows. Does It Have More Upside in 2024?Photo, wide shot, wide-angle lens,  Fashion store, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.theapi.app/temp/4103ce22-87d6-4bef-ba44-0baf5ab280bb.png
Dollar General Stock Has Rebounded 40% From Its Recent Lows. Does It Have More Upside in 2024?

After decades on the public markets, discount retail chain Dollar General (NYSE: DG) was taken private in 2007. Its days as a privately held company, however, were short-lived. Dollar General went

3 Must-Know Facts About Starbucks Before You Buy the StockPhoto, wide shot, wide-angle lens,  Retail store, neutral atmosphere, photo by Joe Cornish: https://img.theapi.app/temp/5574eb69-dc38-42f3-aadd-6163ac8bd4a8.png
3 Must-Know Facts About Starbucks Before You Buy the Stock

With a staggering number of locations scattered across the globe, Starbucks (NASDAQ: SBUX) is a ubiquitous business. Founded in 1971, the company has ascended to becoming the king of the retail

Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the OppositePhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Ozempic Won't Sink This Medical Device Stock's Prospects -- Quite the Opposite

Anti-obesity drugs rose in popularity last year, helping the leaders in this market -- notably Eli Lilly and Novo Nordisk -- crush the market. However, some medical device specialists got the wrong

Will AMD Be a $1 Trillion Company by 2030?Photo, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Will AMD Be a $1 Trillion Company by 2030?

One of the most important pillars in artificial intelligence (AI) is semiconductors. These chips, commonly referred to as graphics processing units (GPUs) and central processing units (CPUs), play

Better Buy: Eli Lilly vs. Viking TherapeuticsPhoto, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
Better Buy: Eli Lilly vs. Viking Therapeutics

Comparing Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) might initially seem odd. The two drugmakers don't seem to have much in common. Eli Lilly is more than 50 times the size of